-
Study: Energy Dept Lab Generates $271 Million for State
An economic study estimates that the Thomas Jefferson National Accelerator Facility, a U.S. Department of Energy nuclear physics research laboratory in Newport News, Virginia, generates more than $271 million in economic output and 2,200 jobs in Virginia. The study for Jefferson Science Associates LLC, the contract operators of the lab, was conducted by The Wessex…
-
Formula Devised to Better Place Wind Farm Turbines
Engineers in the U.S. and Belgium have developed a formula to help wind farm planners arrange the most effective placement of wind energy turbines. Charles Meneveau of Johns Hopkins University in Baltimore, Maryland and Johan Meyers at Katholieke Universiteit Leuven in Belgium presented their findings at a recent meeting of the American Physical Society’s Division…
-
FDA Plans Update of Medical Device Review Process
The U.S. Food and Drug Administration (FDA) has released a plan with 25 actions it intends to implement in 2011, which it says will improve the path to market for many medical devices. The new procedures affect the “510(k) process,” named for the section of FDA’s enabling legislation that applies to medical device approval. Before…
-
Engineers Develop Improved Computer Memory Device
Researchers from North Carolina State University in Raleigh have developed a new device that its inventors say can make large banks of computers more energy efficient, and allow computers to start more quickly. The advance, developed by a faculty-student team from NC State’s engineering school, will be published in an upcoming issue of the IEEE…
-
Math Model Analyzes Moving Bottlenecks in Traffic
A trio of researchers in Italy has developed a mathematical model for a common cause of traffic jams, the slow-moving vehicle, such as a farm tractor or heavy truck, on a crowded highway. The team of Corrado Lattanzio and Amelio Maurizi from University of L’Aquila, with Benedetto Piccoli of Italy’s Institute in Applied Mathematics, published…
-
Stem Cells Shown to Help Treat Spinal Cord Injuries
A study by researchers from Case Western Reserve University School of Medicine in Cleveland, Ohio and Athersys Inc., a drug discovery company also in Cleveland, found adult stem cells can help treat spinal cord injuries in rodents. The study tested Athersys’s MultiStem product made of adult (non-embryonic) stem cells obtained from bone marrow. The findings…
-
Trial Shows Tele-Rehab Results Similar to Standard Methods
Knee replacement patients undergoing tele-rehabilitation, a postoperative rehabilitation program conducted from a remote setting like the patient’s home, experience similar results as patients who undergo traditional postoperative rehabilitation. Findings from this new study were published in the 19 January 2011 issue of the Journal of Bone and Joint Surgery. The research, conducted as a clinical…
-
Report: Tech Industry Clusters Help Build Regional Economies
A new report from the Brookings Institution, a public policy research institute in Washington, D.C., urges the nation’s governors to create innovative new businesses in their states by building on current clusters of enterprises rather than trying to steal companies from other states. The report says this strategy, documented with examples of science and technology-based…
-
Theraclone, Pfizer to Partner on Antibody R&D
Theraclone Sciences Inc., a drug discovery and development company in Seattle, Washington, said today it agreed to a multi-year research and development collaboration with the global pharmaceutical company Pfizer. The deal involves use of Theraclone’s I-STAR technology to discover monoclonal antibodies against up to four targets in the areas of infectious disease and cancer. The…
-
Patent Granted for Lung Disorder Treatment
Discovery Laboratories Inc., a biotechnology company in Warrington, Pennsylvania, said today the company received a U.S. patent for its treatment of pulmonary inflammation. The patent — number 7,863,241 — expires in 2023. Discovery Labs says the patent covers its KL4 peptide (also known as sinapultide), an engineered pulmonary surfactant that lowers surface tension and promote…